Get started
Biohaven Ltd.Biohaven Ltd.Biohaven Ltd.

Biohaven Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

BHVN chart


Full chart

Key facts today


Biohaven Ltd. has withdrawn its application for Dazluma to treat spinocerebellar ataxia genotype 3 after the EMA raised concerns about its effectiveness, causing shares to drop over 11%.
Analyze the impactAnalyze the impact

BHVN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.19 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.39 USD
Net income (FY)
‪−846.42 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪89.15 M‬
Beta (1Y)
1.99

Employees


Employees (FY)
256
Change (1Y)
+17 +7.11%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.31 M‬ USD

About Biohaven Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vladimir Coric
Website
biohaven.com
Headquarters
New Haven
Founded
2022
FIGI
BBG017BXV3Q9
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BHVN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where BHVN is featured.

See all sparks 


Check out other big names from the same industry as BHVN.

Frequently Asked Questions


The current price of BHVN is 19.84 USD — it has increased by 9.29% in the past 24 hours. Watch Biohaven Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Biohaven Ltd. stocks are traded under the ticker BHVN.
BHVN stock has risen by 23.22% compared to the previous week, the month change is a −24.25% fall, over the last year Biohaven Ltd. has showed a −49.06% decrease.
We've gathered analysts' opinions on Biohaven Ltd. future price: according to them, BHVN price has a max estimate of 75.00 USD and a min estimate of 39.00 USD. Watch BHVN chart and read a more detailed Biohaven Ltd. stock forecast: see what analysts think of Biohaven Ltd. and suggest that you do with its stocks.
BHVN reached its all-time high on Mar 8, 2024 with the price of 62.21 USD, and its all-time low was 5.54 USD and was reached on Oct 3, 2022. View more price dynamics on BHVN chart.
See other stocks reaching their highest and lowest prices.
BHVN stock is 34.33% volatile and has beta coefficient of 1.99. Track Biohaven Ltd. stock price on the chart and check out the list of the most volatile stocks — is Biohaven Ltd. there?
Today Biohaven Ltd. has the market capitalization of ‪2.39 B‬, it has increased by 15.61% over the last week.
Yes, you can track Biohaven Ltd. financials in yearly and quarterly reports right on TradingView.
Biohaven Ltd. is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.
BHVN earnings for the last quarter are −1.85 USD per share, whereas the estimation was −1.57 USD resulting in a −17.47% surprise. The estimated earnings for the next quarter are −1.69 USD per share. See more details about Biohaven Ltd. earnings.
Biohaven Ltd. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach ‪1.56 M‬ USD.
BHVN net income for the last quarter is ‪−186.84 M‬ USD, while the quarter before that showed ‪−160.30 M‬ USD of net income which accounts for −16.56% change. Track more Biohaven Ltd. financial stats to get the full picture.
No, BHVN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 256 employees. See our rating of the largest employees — is Biohaven Ltd. on this list?
Like other stocks, BHVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biohaven Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biohaven Ltd. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biohaven Ltd. stock shows the sell signal. See more of Biohaven Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.